North Star Asset Management Inc Haemonetics Corp Transaction History

North Star Asset Management Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 24, 2020	SELL	$74.34 - $121.82 $208,152 - $341,096	-2,800 Closed	0 $0
Q4 2019 Feb 06, 2020	SELL	$114.37 - $129.46 $57,185 - $64,730	-500 Reduced 15.15%	2,800 $322,000
Q2 2018 Aug 10, 2018	SELL	$71.53 - $95.75 $14,306 - $19,150	-200 Reduced 5.71%	3,300 $296,000
Q1 2018 Apr 27, 2018	SELL	$60.72 - $74.41 $18,216 - $22,323	-300 Reduced 7.89%	3,500 $256,000
Q4 2017 Feb 01, 2018	SELL	$44.96 - $58.99 $303,480 - $398,182	-6,750 Reduced 63.98%	3,800 $221,000
Q3 2017 Oct 25, 2017	SELL	$40.38 - $44.87 $932,576 - $1.04 Million	-23,095 Reduced 68.64%	10,550 $473,000
Q3 2017 Oct 25, 2017	BUY	$40.38 - $44.87 $431,460 - $479,435	10,685 Added 46.54%	33,645 $1.37 Million
Q2 2017 Aug 16, 2017	BUY	N/A	22,960	22,960 $907,000

347

51.8M

600K

474K

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $3.31B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

Get notified when there are updates to the investment portfolio of North Star Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on North Star Asset Management Inc with notifications on news.